(function(){ var content_array=["

關于DR.CI:LABO?<\/b> <\/p> \n

自1999年以來,DR.CI:LABO?始終引領膠原蛋白健康護膚解決方案的發展。25年多來,DR.CI:LABO?致力于提供護膚解決方案,釋放每寸肌膚蘊含的美麗潛能,并讓所有人都能享受到專業的護理。<\/p> \n

\n \n \n \n \n \n \n \n \n
<noscript id="kgssg"><option id="kgssg"></option></noscript><optgroup id="kgssg"><wbr id="kgssg"></wbr></optgroup><optgroup id="kgssg"></optgroup>
<optgroup id="kgssg"><div id="kgssg"></div></optgroup>
<center id="kgssg"><div id="kgssg"></div></center>
<center id="kgssg"></center>
久久久亚洲欧洲日产国码二区

[1] Intense Pulsed Light<\/span> <\/p> <\/td> \n <\/tr> \n

[2] Taichi Nishizawa et. al., "Ex-vivo and Clinical Study of an Amphiphilic Vitamin C Derivative to Enhance Dermal Collagen and Skin Gloss", IMACS Asia 2025, 6-8 June 2025, Bangkok, Thailand<\/span> <\/p> <\/td> \n <\/tr> \n

[3] Frequency of IPL treatment administered: 3 times every 2 weeks, over 8 weeks (IPL output: 10-13J, about 100 shots).  <\/span> <\/p> <\/td> \n <\/tr> \n

[4] Masahiko Ando et. al., Clinical efficacy assessment of skin care formulations containing trisodium ascorbyl6-palmitate 2-phosphate (APPS) for pre-aging skin, Poster number 61671, American Academy of Dermatology Annual Meeting, 7-11 March 2025, Orlando, Florida<\/span> <\/p> <\/td> \n <\/tr> \n

[5] Yueying Fu et. al., "Clinical Safety and Efficacy of a Novel Topical Phenylethyl Resorcinol Formulation for Intense Pulsed Light Adjunctive Usage for Solar Lentigo and Melasma skin", IMACS Asia 2025, 6-8 June 2025, Bangkok, Thailand<\/span> <\/p> <\/td> \n <\/tr> \n

[6] Joleen Goh et. al., "Knowledge, Attitude, and Practice Towards the Adjunctive Perioperative Use of Phenylethyl Resorcinol with Aesthetic Treatments", IMACS Asia 2025, 6-8 June 2025, Bangkok, Thailand<\/span> <\/p> <\/td> \n <\/tr> \n <\/tbody> \n <\/table> \n<\/div> \n

 <\/p> \n

 <\/p> \n

<\/div> \n\"\""]; $("#dvExtra").html(content_array[0]);})();
<center id="kgssg"></center>
<center id="kgssg"><wbr id="kgssg"></wbr></center>